The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and Prognosis

Zaimy, M.A.; Saffarzadeh, N.; Mohammadi, A.; Pourghadamyari, H.; Izadi, P.; Sarli, A.; Moghaddam, L.K.; Paschepari, S.R.; Azizi, H.; Torkamandi, S.; Bazzaz, T.J. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther., 2017, 24(6), 233-243.
[http://dx.doi.org/10.1038/cgt.2017.16] [PMID: 28574057]

Cronin, K.A.; Lake, A.J.; Scott, S.; Sherman, R.L.; Noone, A.M.; Howlader, N.; Henley, S.J.; Anderson, R.N.; Firth, A.U.; Ma, J.; Kohler, B.A.; Jemal, A. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer, 2018, 124(13), 2785-2800.
[http://dx.doi.org/10.1002/cncr.31551] [PMID: 29786848]

Kocianova, E.; Piatrikova, V.; Golias, T. Revisiting the warburg effect with focus on lactate. Cancers, 2022, 14(24), 6028.
[http://dx.doi.org/10.3390/cancers14246028] [PMID: 36551514]

Payen, V.L.; Mina, E.; Hée, V.V.F.; Porporato, P.E.; Sonveaux, P. Monocarboxylate transporters in cancer. Mol. Metab., 2020, 33, 48-66.
[http://dx.doi.org/10.1016/j.molmet.2019.07.006] [PMID: 31395464]

Wang, Z.; Jensen, M.A.; Zenklusen, J.C. A practical guide to the cancer genome atlas (TCGA). Methods Mol. Biol., 2016, 1418, 111-141.
[http://dx.doi.org/10.1007/978-1-4939-3578-9_6] [PMID: 27008012]

Gao, J.; Aksoy, B.A.; Dogrusoz, U.; Dresdner, G.; Gross, B.; Sumer, S.O.; Sun, Y.; Jacobsen, A.; Sinha, R.; Larsson, E.; Cerami, E.; Sander, C.; Schultz, N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 2013, 6(269), pl1.
[http://dx.doi.org/10.1126/scisignal.2004088] [PMID: 23550210]

Cerami, E.; Gao, J.; Dogrusoz, U.; Gross, B.E.; Sumer, S.O.; Aksoy, B.A.; Jacobsen, A.; Byrne, C.J.; Heuer, M.L.; Larsson, E.; Antipin, Y.; Reva, B.; Goldberg, A.P.; Sander, C.; Schultz, N. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2012, 2(5), 401-404.
[http://dx.doi.org/10.1158/2159-8290.CD-12-0095] [PMID: 22588877]

Vega, S.F.; Mina, M.; Armenia, J.; Chatila, W.K.; Luna, A.; La, K.C.; Dimitriadoy, S.; Liu, D.L.; Kantheti, H.S.; Saghafinia, S.; Chakravarty, D.; Daian, F.; Gao, Q.; Bailey, M.H.; Liang, W.W.; Foltz, S.M.; Shmulevich, I.; Ding, L.; Heins, Z.; Ochoa, A.; Gross, B.; Gao, J.; Zhang, H.; Kundra, R.; Kandoth, C.; Bahceci, I.; Dervishi, L.; Dogrusoz, U.; Zhou, W.; Shen, H.; Laird, P.W.; Way, G.P.; Greene, C.S.; Liang, H.; Xiao, Y.; Wang, C.; Iavarone, A.; Berger, A.H.; Bivona, T.G.; Lazar, A.J.; Hammer, G.D.; Giordano, T.; Kwong, L.N.; McArthur, G.; Huang, C.; Tward, A.D.; Frederick, M.J.; McCormick, F.; Meyerson, M.; Allen, V.E.M.; Cherniack, A.D.; Ciriello, G.; Sander, C.; Schultz, N.; Johnson, C.S.J.; Demchok, J.A.; Felau, I.; Kasapi, M.; Ferguson, M.L.; Hutter, C.M.; Sofia, H.J.; Tarnuzzer, R.; Wang, Z.; Yang, L.; Zenklusen, J.C.; Zhang, J.J.; Chudamani, S.; Liu, J.; Lolla, L.; Naresh, R.; Pihl, T.; Sun, Q.; Wan, Y.; Wu, Y.; Cho, J.; DeFreitas, T.; Frazer, S.; Gehlenborg, N.; Getz, G.; Heiman, D.I.; Kim, J.; Lawrence, M.S.; Lin, P.; Meier, S.; Noble, M.S.; Saksena, G.; Voet, D.; Zhang, H.; Bernard, B.; Chambwe, N.; Dhankani, V.; Knijnenburg, T.; Kramer, R.; Leinonen, K.; Liu, Y.; Miller, M.; Reynolds, S.; Shmulevich, I.; Thorsson, V.; Zhang, W.; Akbani, R.; Broom, B.M.; Hegde, A.M.; Ju, Z.; Kanchi, R.S.; Korkut, A.; Li, J.; Liang, H.; Ling, S.; Liu, W.; Lu, Y.; Mills, G.B.; Ng, K-S.; Rao, A.; Ryan, M.; Wang, J.; Weinstein, J.N.; Zhang, J.; Abeshouse, A.; Armenia, J.; Chakravarty, D.; Chatila, W.K.; de Bruijn, I.; Gao, J.; Gross, B.E.; Heins, Z.J.; Kundra, R.; La, K.; Ladanyi, M.; Luna, A.; Nissan, M.G.; Ochoa, A.; Phillips, S.M.; Reznik, E.; Vega, S.F.; Sander, C.; Schultz, N.; Sheridan, R.; Sumer, S.O.; Sun, Y.; Taylor, B.S.; Wang, J.; Zhang, H.; Anur, P.; Peto, M.; Spellman, P.; Benz, C.; Stuart, J.M.; Wong, C.K.; Yau, C.; Hayes, D.N.; Parker, J.S.; Wilkerson, M.D.; Ally, A.; Balasundaram, M.; Bowlby, R.; Brooks, D.; Carlsen, R.; Chuah, E.; Dhalla, N.; Holt, R.; Jones, S.J.M.; Kasaian, K.; Lee, D.; Ma, Y.; Marra, M.A.; Mayo, M.; Moore, R.A.; Mungall, A.J.; Mungall, K.; Robertson, A.G.; Sadeghi, S.; Schein, J.E.; Sipahimalani, P.; Tam, A.; Thiessen, N.; Tse, K.; Wong, T.; Berger, A.C.; Beroukhim, R.; Cherniack, A.D.; Cibulskis, C.; Gabriel, S.B.; Gao, G.F.; Ha, G.; Meyerson, M.; Schumacher, S.E.; Shih, J.; Kucherlapati, M.H.; Kucherlapati, R.S.; Baylin, S.; Cope, L.; Danilova, L.; Bootwalla, M.S.; Lai, P.H.; Maglinte, D.T.; Berg, V.D.D.J.; Weisenberger, D.J.; Auman, J.T.; Balu, S.; Bodenheimer, T.; Fan, C.; Hoadley, K.A.; Hoyle, A.P.; Jefferys, S.R.; Jones, C.D.; Meng, S.; Mieczkowski, P.A.; Mose, L.E.; Perou, A.H.; Perou, C.M.; Roach, J.; Shi, Y.; Simons, J.V.; Skelly, T.; Soloway, M.G.; Tan, D.; Veluvolu, U.; Fan, H.; Hinoue, T.; Laird, P.W.; Shen, H.; Zhou, W.; Bellair, M.; Chang, K.; Covington, K.; Creighton, C.J.; Dinh, H.; Doddapaneni, H.V.; Donehower, L.A.; Drummond, J.; Gibbs, R.A.; Glenn, R.; Hale, W.; Han, Y.; Hu, J.; Korchina, V.; Lee, S.; Lewis, L.; Li, W.; Liu, X.; Morgan, M.; Morton, D.; Muzny, D.; Santibanez, J.; Sheth, M.; Shinbrot, E.; Wang, L.; Wang, M.; Wheeler, D.A.; Xi, L.; Zhao, F.; Hess, J.; Appelbaum, E.L.; Bailey, M.; Cordes, M.G.; Ding, L.; Fronick, C.C.; Fulton, L.A.; Fulton, R.S.; Kandoth, C.; Mardis, E.R.; McLellan, M.D.; Miller, C.A.; Schmidt, H.K.; Wilson, R.K.; Crain, D.; Curley, E.; Gardner, J.; Lau, K.; Mallery, D.; Morris, S.; Paulauskis, J.; Penny, R.; Shelton, C.; Shelton, T.; Sherman, M.; Thompson, E.; Yena, P.; Bowen, J.; Foster, G.J.M.; Gerken, M.; Leraas, K.M.; Lichtenberg, T.M.; Ramirez, N.C.; Wise, L.; Zmuda, E.; Corcoran, N.; Costello, T.; Hovens, C.; Carvalho, A.L.; de Carvalho, A.C.; Fregnani, J.H.; Filho, L.A.; Reis, R.M.; Neto, S.C.; Silveira, H.C.S.; Vidal, D.O.; Burnette, A.; Eschbacher, J.; Hermes, B.; Noss, A.; Singh, R.; Anderson, M.L.; Castro, P.D.; Ittmann, M.; Huntsman, D.; Kohl, B.; Le, X.; Thorp, R.; Andry, C.; Duffy, E.R.; Lyadov, V.; Paklina, O.; Setdikova, G.; Shabunin, A.; Tavobilov, M.; McPherson, C.; Warnick, R.; Berkowitz, R.; Cramer, D.; Feltmate, C.; Horowitz, N.; Kibel, A.; Muto, M.; Raut, C.P.; Malykh, A.; Sloan, B.J.S.; Barrett, W.; Devine, K.; Fulop, J.; Ostrom, Q.T.; Shimmel, K.; Wolinsky, Y.; Sloan, A.E.; De Rose, A.; Giuliante, F.; Goodman, M.; Karlan, B.Y.; Hagedorn, C.H.; Eckman, J.; Harr, J.; Myers, J.; Tucker, K.; Zach, L.A.; Deyarmin, B.; Hu, H.; Kvecher, L.; Larson, C.; Mural, R.J.; Somiari, S.; Vicha, A.; Zelinka, T.; Bennett, J.; Iacocca, M.; Rabeno, B.; Swanson, P.; Latour, M.; Lacombe, L.; Têtu, B.; Bergeron, A.; McGraw, M.; Staugaitis, S.M.; Chabot, J.; Hibshoosh, H.; Sepulveda, A.; Su, T.; Wang, T.; Potapova, O.; Voronina, O.; Desjardins, L.; Mariani, O.; Roman-Roman, S.; Sastre, X.; Stern, M-H.; Cheng, F.; Signoretti, S.; Berchuck, A.; Bigner, D.; Lipp, E.; Marks, J.; McCall, S.; McLendon, R.; Secord, A.; Sharp, A.; Behera, M.; Brat, D.J.; Chen, A.; Delman, K.; Force, S.; Khuri, F.; Magliocca, K.; Maithel, S.; Olson, J.J.; Owonikoko, T.; Pickens, A.; Ramalingam, S.; Shin, D.M.; Sica, G.; Meir, V.E.G.; Zhang, H.; Eijckenboom, W.; Gillis, A.; Korpershoek, E.; Looijenga, L.; Oosterhuis, W.; Stoop, H.; Kessel, V.K.E.; Zwarthoff, E.C.; Calatozzolo, C.; Cuppini, L.; Cuzzubbo, S.; DiMeco, F.; Finocchiaro, G.; Mattei, L.; Perin, A.; Pollo, B.; Chen, C.; Houck, J.; Lohavanichbutr, P.; Hartmann, A.; Stoehr, C.; Stoehr, R.; Taubert, H.; Wach, S.; Wullich, B.; Kycler, W.; Murawa, D.; Wiznerowicz, M.; Chung, K.; Edenfield, W.J.; Martin, J.; Baudin, E.; Bubley, G.; Bueno, R.; Rienzo, D.A.; Richards, W.G.; Kalkanis, S.; Mikkelsen, T.; Noushmehr, H.; Scarpace, L.; Girard, N.; Aymerich, M.; Campo, E.; Giné, E.; Guillermo, A.L.; Bang, V.N.; Hanh, P.T.; Phu, B.D.; Tang, Y.; Colman, H.; Evason, K.; Dottino, P.R.; Martignetti, J.A.; Gabra, H.; Juhl, H.; Akeredolu, T.; Stepa, S.; Hoon, D.; Ahn, K.; Kang, K.J.; Beuschlein, F.; Breggia, A.; Birrer, M.; Bell, D.; Borad, M.; Bryce, A.H.; Castle, E.; Chandan, V.; Cheville, J.; Copland, J.A.; Farnell, M.; Flotte, T.; Giama, N.; Ho, T.; Kendrick, M.; Kocher, J-P.; Kopp, K.; Moser, C.; Nagorney, D.; O’Brien, D.; O’Neill, B.P.; Patel, T.; Petersen, G.; Que, F.; Rivera, M.; Roberts, L.; Smallridge, R.; Smyrk, T.; Stanton, M.; Thompson, R.H.; Torbenson, M.; Yang, J.D.; Zhang, L.; Brimo, F.; Ajani, J.A.; Gonzalez, A.M.A.; Behrens, C.; Bondaruk, J.; Broaddus, R.; Czerniak, B.; Esmaeli, B.; Fujimoto, J.; Gershenwald, J.; Guo, C.; Lazar, A.J.; Logothetis, C.; Bernstam, M.F.; Moran, C.; Ramondetta, L.; Rice, D.; Sood, A.; Tamboli, P.; Thompson, T.; Troncoso, P.; Tsao, A.; Wistuba, I.; Carter, C.; Haydu, L.; Hersey, P.; Jakrot, V.; Kakavand, H.; Kefford, R.; Lee, K.; Long, G.; Mann, G.; Quinn, M.; Saw, R.; Scolyer, R.; Shannon, K.; Spillane, A.; Stretch, J.; Synott, M.; Thompson, J.; Wilmott, J.; Ahmadie, A.H.; Chan, T.A.; Ghossein, R.; Gopalan, A.; Levine, D.A.; Reuter, V.; Singer, S.; Singh, B.; Tien, N.V.; Broudy, T.; Mirsaidi, C.; Nair, P.; Drwiega, P.; Miller, J.; Smith, J.; Zaren, H.; Park, J-W.; Hung, N.P.; Kebebew, E.; Linehan, W.M.; Metwalli, A.R.; Pacak, K.; Pinto, P.A.; Schiffman, M.; Schmidt, L.S.; Vocke, C.D.; Wentzensen, N.; Worrell, R.; Yang, H.; Moncrieff, M.; Goparaju, C.; Melamed, J.; Pass, H.; Botnariuc, N.; Caraman, I.; Cernat, M.; Chemencedji, I.; Clipca, A.; Doruc, S.; Gorincioi, G.; Mura, S.; Pirtac, M.; Stancul, I.; Tcaciuc, D.; Albert, M.; Alexopoulou, I.; Arnaout, A.; Bartlett, J.; Engel, J.; Gilbert, S.; Parfitt, J.; Sekhon, H.; Thomas, G.; Rassl, D.M.; Rintoul, R.C.; Bifulco, C.; Tamakawa, R.; Urba, W.; Hayward, N.; Timmers, H.; Antenucci, A.; Facciolo, F.; Grazi, G.; Marino, M.; Merola, R.; de Krijger, R.; Roqueplo, G.A-P.; Piché, A.; Chevalier, S.; McKercher, G.; Birsoy, K.; Barnett, G.; Brewer, C.; Farver, C.; Naska, T.; Pennell, N.A.; Raymond, D.; Schilero, C.; Smolenski, K.; Williams, F.; Morrison, C.; Borgia, J.A.; Liptay, M.J.; Pool, M.; Seder, C.W.; Junker, K.; Omberg, L.; Dinkin, M.; Manikhas, G.; Alvaro, D.; Bragazzi, M.C.; Cardinale, V.; Carpino, G.; Gaudio, E.; Chesla, D.; Cottingham, S.; Dubina, M.; Moiseenko, F.; Dhanasekaran, R.; Becker, K-F.; Janssen, K-P.; Huspenina, S.J.; Rahman, A.M.H.; Aziz, D.; Bell, S.; Cebulla, C.M.; Davis, A.; Duell, R.; Elder, J.B.; Hilty, J.; Kumar, B.; Lang, J.; Lehman, N.L.; Mandt, R.; Nguyen, P.; Pilarski, R.; Rai, K.; Schoenfield, L.; Senecal, K.; Wakely, P.; Hansen, P.; Lechan, R.; Powers, J.; Tischler, A.; Grizzle, W.E.; Sexton, K.C.; Kastl, A.; Henderson, J.; Porten, S.; Waldmann, J.; Fassnacht, M.; Asa, S.L.; Schadendorf, D.; Couce, M.; Graefen, M.; Huland, H.; Sauter, G.; Schlomm, T.; Simon, R.; Tennstedt, P.; Olabode, O.; Nelson, M.; Bathe, O.; Carroll, P.R.; Chan, J.M.; Disaia, P.; Glenn, P.; Kelley, R.K.; Landen, C.N.; Phillips, J.; Prados, M.; Simko, J.; McCune, S.K.; VandenBerg, S.; Roggin, K.; Fehrenbach, A.; Kendler, A.; Sifri, S.; Steele, R.; Jimeno, A.; Carey, F.; Forgie, I.; Mannelli, M.; Carney, M.; Hernandez, B.; Campos, B.; Mende, H.C.; Jungk, C.; Unterberg, A.; Deimling, V.A.; Bossler, A.; Galbraith, J.; Jacobus, L.; Knudson, M.; Knutson, T.; Ma, D.; Milhem, M.; Sigmund, R.; Godwin, A.K.; Madan, R.; Rosenthal, H.G.; Adebamowo, C.; Adebamowo, S.N.; Boussioutas, A.; Beer, D.; Giordano, T.; Masson, M.A-M.; Saad, F.; Bocklage, T.; Landrum, L.; Mannel, R.; Moore, K.; Moxley, K.; Postier, R.; Walker, J.; Zuna, R.; Feldman, M.; Valdivieso, F.; Dhir, R.; Luketich, J.; Pinero, E.M.M.; Aguilo, Q.M.; Carlotti, C.G., Jr; Santos, D.J.S.; Kemp, R.; Sankarankuty, A.; Tirapelli, D.; Catto, J.; Agnew, K.; Swisher, E.; Creaney, J.; Robinson, B.; Shelley, C.S.; Godwin, E.M.; Kendall, S.; Shipman, C.; Bradford, C.; Carey, T.; Haddad, A.; Moyer, J.; Peterson, L.; Prince, M.; Rozek, L.; Wolf, G.; Bowman, R.; Fong, K.M.; Yang, I.; Korst, R.; Rathmell, W.K.; Campbell, F.J.L.; Hooke, J.A.; Kovatich, A.J.; Shriver, C.D.; DiPersio, J.; Drake, B.; Govindan, R.; Heath, S.; Ley, T.; Tine, V.B.; Westervelt, P.; Rubin, M.A.; Lee, J.I.; Aredes, N.D.; Mariamidze, A. Oncogenic signaling pathways in the cancer genome atlas. Cell, 2018, 173(2), 321-337.e10.
[http://dx.doi.org/10.1016/j.cell.2018.03.035] [PMID: 29625050]

Yuan, C.; Wang, B.; Chen, J.; Lin, C.; Liu, R.; Wang, L. MCM3AP-AS1: A lncrna participating in the tumorigenesis of cancer through multiple pathways. Mini Rev. Med. Chem., 2022, 22(16), 2138-2145.
[http://dx.doi.org/10.2174/1389557522666220214100718] [PMID: 35156580]

Hu, C. LncRNA DSCAM-AS1: A pivotal therapeutic target in cancer. Mini Rev. Med. Chem., 2023, 23(5), 530-536.
[http://dx.doi.org/10.2174/1389557522666220822121935] [PMID: 35996247]

Wang, B.; Chen, J. AGAP2-AS1: An indispensable lncRNA in tumors. Mini Rev. Med. Chem., 2023, 23(3), 336-342.
[http://dx.doi.org/10.2174/1389557522666220615154227] [PMID: 35708074]

Lv, X.; Zhang, M.; Xu, W. The value of emerging prostate cancer-associated lncRNA PCGEM1 in various tumors. Mini Rev. Med. Chem., 2023, 23(22), 2090-2096.
[http://dx.doi.org/10.2174/1389557523666230313144742] [PMID: 36915991]

Chen, X.; Liu, K.; Xu, W.; Zhou, G.; Yuan, C. Tumor-related molecular regulatory mechanisms of long non-coding RNA RMST: Recent evidence. Mini Rev. Med. Chem., 2022, 22(10), 1374-1379.
[http://dx.doi.org/10.2174/1389557521666211202150646] [PMID: 34856896]

Jin, Y.; Qin, X. Comprehensive analysis of transcriptome data for identifying biomarkers and therapeutic targets in head and neck squamous cell carcinoma. Ann. Transl. Med., 2020, 8(6), 282.
[http://dx.doi.org/10.21037/atm.2020.03.30] [PMID: 32355726]

Fox, S.A.; Vacher, M.; Farah, C.S. Transcriptomic biomarker signatures for discrimination of oral cancer surgical margins. Biomolecules, 2022, 12(3), 464.
[http://dx.doi.org/10.3390/biom12030464] [PMID: 35327656]

Romaszko, A.; Doboszyńska, A. Multiple primary lung cancer: A literature review. Adv. Clin. Exp. Med., 2018, 27(5), 725-730.
[http://dx.doi.org/10.17219/acem/68631] [PMID: 29790681]

Balendiran, G.K.; Dabur, R.; Fraser, D. The role of glutathione in cancer. Cell Biochem. Funct., 2004, 22(6), 343-352.
[http://dx.doi.org/10.1002/cbf.1149] [PMID: 15386533]

Yang, P.; Ebbert, J.O.; Sun, Z.; Weinshilboum, R.M. Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. J. Clin. Oncol., 2006, 24(11), 1761-1769.
[http://dx.doi.org/10.1200/JCO.2005.02.7110] [PMID: 16603718]

Doherty, J.R.; Yang, C.; Scott, K.E.N.; Cameron, M.D.; Fallahi, M.; Li, W.; Hall, M.A.; Amelio, A.L.; Mishra, J.K.; Li, F.; Tortosa, M.; Genau, H.M.; Rounbehler, R.J.; Lu, Y.; Dang, C.V.; Kumar, K.G.; Butler, A.A.; Bannister, T.D.; Hooper, A.T.; Kacmaz, U.K.; Roush, W.R.; Cleveland, J.L. Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res., 2014, 74(3), 908-920.
[http://dx.doi.org/10.1158/0008-5472.CAN-13-2034] [PMID: 24285728]

Dai, J.; Li, Z.; Amos, C.I.; Hung, R.J.; Tardon, A.; Andrew, A.S.; Chen, C.; Christiani, D.C.; Albanes, D.; Heijden, V.D.E.H.F.M.; Duell, E.J.; Rennert, G.; Mckay, J.D.; Yuan, J.M.; Field, J.K.; Manjer, J.; Grankvist, K.; Marchand, L.L.; Teare, M.D.; Schabath, M.B.; Aldrich, M.C.; Tsao, M.S.; Lazarus, P.; Lam, S.; Bojesen, S.E.; Arnold, S.; Wu, X.; Haugen, A.; Janout, V.; Johansson, M.; Brhane, Y.; Somoano, F.A.; Kiemeney, L.A.; Davies, M.P.A.; Zienolddiny, S.; Hu, Z.; Shen, H. Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis, 2019, 40(3), 432-440.
[http://dx.doi.org/10.1093/carcin/bgy187] [PMID: 30590402]

Denisenko, T.V.; Budkevich, I.N.; Zhivotovsky, B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis., 2018, 9(2), 117.
[http://dx.doi.org/10.1038/s41419-017-0063-y] [PMID: 29371589]

Wei, X.; Li, X.; Hu, S.; Cheng, J.; Cai, R. Regulation of ferroptosis in lung adenocarcinoma. Int. J. Mol. Sci., 2023, 24(19), 14614.
[http://dx.doi.org/10.3390/ijms241914614] [PMID: 37834062]

Zhu, H.; Liu, Y.; Wu, Q.; Li, J.; Jia, W.; Zhai, X.; Yu, J. Comprehensive analysis and validation of competing endogenous RNA network and tumor-infiltrating immune cells in lung adenocarcinoma. Comb. Chem. High Throughput Screen., 2022, 25(13), 2240-2254.
[http://dx.doi.org/10.2174/1386207325666220324092231] [PMID: 35331104]

Stewart, P.A.; Parapatics, K.; Welsh, E.A.; Müller, A.C.; Cao, H.; Fang, B.; Koomen, J.M.; Eschrich, S.A.; Bennett, K.L.; Haura, E.B. A pilot proteogenomic study with data integration identifies mct1 and glut1 as prognostic markers in lung adenocarcinoma. PLoS One, 2015, 10(11), e0142162.
[http://dx.doi.org/10.1371/journal.pone.0142162] [PMID: 26539827]

Park, J-H.; Lee, J-Y.; Shin, D-H.; Jang, K-S.; Kim, H-J.; Kong, G. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway. Oncogene, 2011, 30(45), 4578-4589.
[http://dx.doi.org/10.1038/onc.2011.174] [PMID: 21602890]

Abraham, A.G.; O’Neill, E. PI3K/Akt-mediated regulation of p53 in cancer. Biochem. Soc. Trans., 2014, 42(4), 798-803.
[http://dx.doi.org/10.1042/BST20140070] [PMID: 25109960]

Noorolyai, S.; Shajari, N.; Baghbani, E.; Sadreddini, S.; Baradaran, B. The relation between PI3K/AKT signalling pathway and cancer. Gene, 2019, 698, 120-128.
[http://dx.doi.org/10.1016/j.gene.2019.02.076] [PMID: 30849534]

Kim, S.Y.; Kim, D.; Kim, J.; Ko, H.Y.; Kim, W.J.; Park, Y.; Lee, H.W.; Han, D.H.; Kim, K.S.; Park, S.; Lee, M.; Yun, M. Extracellular citrate treatment induces hif1α degradation and inhibits the growth of low-glycolytic hepatocellular carcinoma under hypoxia. Cancers, 2022, 14(14), 3355.
[http://dx.doi.org/10.3390/cancers14143355]

Schug, Z.T.; Vande Voorde, J.; Gottlieb, E. The metabolic fate of acetate in cancer. Nat. Rev. Cancer, 2016, 16(11), 708-717.
[http://dx.doi.org/10.1038/nrc.2016.87] [PMID: 27562461]

Gusyatiner, O.; Hegi, M.E. Glioma epigenetics: From subclassification to novel treatment options. Semin. Cancer Biol., 2018, 51, 50-58.
[http://dx.doi.org/10.1016/j.semcancer.2017.11.010] [PMID: 29170066]

Sturm, D.; Filbin, M. Gliomas in children. Semin. Neurol., 2018, 38(1), 121-130.
[http://dx.doi.org/10.1055/s-0038-1635106] [PMID: 29548059]

Lin, H.H.; Tsai, W.C.; Tsai, C.K.; Chen, S.H.; Huang, L.C.; Hueng, D.Y.; Hung, K.C. Overexpression of cell-surface marker slc16a1 shortened survival in human high-grade gliomas. J. Mol. Neurosci., 2021, 71(8), 1614-1621.
[http://dx.doi.org/10.1007/s12031-021-01806-w] [PMID: 33641091]

Li, K.K.W.; Pang, J.C.; Ching, A.K.; Wong, C.K.; Kong, X.; Wang, Y.; Zhou, L.; Chen, Z.; Ng, H. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum. Pathol., 2009, 40(9), 1234-1243.
[http://dx.doi.org/10.1016/j.humpath.2009.02.003] [PMID: 19427019]

Longhitano, L.; Vicario, N.; Tibullo, D.; Giallongo, C.; Broggi, G.; Caltabiano, R.; Barbagallo, G.M.V.; Altieri, R.; Baghini, M.; Rosa, D.M.; Parenti, R.; Giordano, A.; Mione, M.C.; Volti, L.G. Lactate induces the expressions of mct1 and hcar1 to promote tumor growth and progression in glioblastoma. Front. Oncol., 2022, 12, 871798.
[http://dx.doi.org/10.3389/fonc.2022.871798] [PMID: 35574309]

Ghosh, D.; Ulasov, I.V.; Chen, L.; Harkins, L.E.; Wallenborg, K.; Hothi, P.; Rostad, S.; Hood, L.; Cobbs, C.S. TGFβ-Responsive hmox1 expression is associated with stemness and invasion in glioblastoma multiforme. Stem Cells, 2016, 34(9), 2276-2289.
[http://dx.doi.org/10.1002/stem.2411] [PMID: 27354342]

Ghosh, D.; Funk, C.C.; Caballero, J.; Shah, N.; Rouleau, K.; Earls, J.C.; Soroceanu, L.; Foltz, G.; Cobbs, C.S.; Price, N.D.; Hood, L. A cell-surface membrane protein signature for glioblastoma. Cell Syst., 2017, 4(5), 516-529.e7.
[http://dx.doi.org/10.1016/j.cels.2017.03.004] [PMID: 28365151]

Fang, J.; Quinones, Q.J.; Holman, T.L.; Morowitz, M.J.; Wang, Q.; Zhao, H.; Sivo, F.; Maris, J.M.; Wahl, M.L. The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential therapeutic target for high-risk neuroblastoma. Mol. Pharmacol., 2006, 70(6), 2108-2115.
[http://dx.doi.org/10.1124/mol.106.026245] [PMID: 17000864]

Khan, A.; Valli, E.; Lam, H.; Scott, D.A.; Murray, J.; Hanssen, K.M.; Eden, G.; Gamble, L.D.; Pandher, R.; Flemming, C.L.; Allan, S.; Osterman, A.L.; Haber, M.; Norris, M.D.; Fletcher, J.I.; Yu, D.M.T. Targeting metabolic activity in high-risk neuroblastoma through monocarboxylate transporter 1 (mct1) inhibition. Oncogene, 2020, 39(17), 3555-3570.
[http://dx.doi.org/10.1038/s41388-020-1235-2] [PMID: 32123312]

Xie, J.; Zhu, Z.; Cao, Y.; Ruan, S.; Wang, M.; Shi, J. Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma. Channels, 2021, 15(1), 483-495.
[http://dx.doi.org/10.1080/19336950.2021.1953322] [PMID: 34254872]

Avitabile, M.; Succoio, M.; Testori, A.; Cardinale, A.; Vaksman, Z.; Lasorsa, V.A.; Cantalupo, S.; Esposito, M.; Cimmino, F.; Montella, A.; Formicola, D.; Koster, J.; Andreotti, V.; Ghiorzo, P.; Romano, M.F.; Staibano, S.; Scalvenzi, M.; Ayala, F.; Hakonarson, H.; Corrias, M.V.; Devoto, M.; Law, M.H.; Iles, M.M.; Brown, K.; Diskin, S.; Zambrano, N.; Iolascon, A.; Capasso, M. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene. Carcinogenesis, 2020, 41(3), 284-295.
[http://dx.doi.org/10.1093/carcin/bgz153] [PMID: 31605138]

Yu, S.; Wu, Y.; Li, C.; Qu, Z.; Lou, G.; Guo, X.; Ji, J.; Li, N.; Guo, M.; Zhang, M.; Lei, L.; Tai, S. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics. Sci. Rep., 2020, 10(1), 7315.
[http://dx.doi.org/10.1038/s41598-020-64356-y] [PMID: 32355273]

Zhang, L.; Song, Z.S.; Wang, Z.S.; Guo, Y.L.; Xu, C.G.; Shen, H. High expression of slc16a1 as a biomarker to predict poor prognosis of urological cancers. Front. Oncol., 2021, 11, 706883.
[http://dx.doi.org/10.3389/fonc.2021.706883] [PMID: 34631536]

Sanchis, P.; Anselmino, N.; Vickers, L.S.; Sabater, A.; Lavignolle, R.; Labanca, E.; Shepherd, P.D.A.; Bizzotto, J.; Toro, A.; Mitrofanova, A.; Valacco, M.P.; Navone, N.; Vazquez, E.; Cotignola, J.; Gueron, G. Bone progenitors pull the strings on the early metabolic rewiring occurring in prostate cancer cells. Cancers, 2022, 14(9), 2083.
[http://dx.doi.org/10.3390/cancers14092083] [PMID: 35565211]

Sathe, A.; Nawroth, R. Targeting the pi3k/akt/mtor pathway in bladder cancer. Methods Mol. Biol., 2018, 1655, 335-350.
[http://dx.doi.org/10.1007/978-1-4939-7234-0_23] [PMID: 28889395]

Mustanjid, A.M.; Mahmud, S.M.H.; Royel, M.R.I.; Rahman, M.H.; Islam, T.; Rahman, M.R.; Moni, M.A. Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: A bioinformatics and systems biology approach. Genomics, 2020, 112(5), 3416-3426.
[http://dx.doi.org/10.1016/j.ygeno.2020.06.001] [PMID: 32535071]

Haraldsdottir, S.; Einarsdottir, H.M.; Smaradottir, A.; Gunnlaugsson, A.; Halfdanarson, T.R. [Colorectal cancer - review]. Laeknabladid, 2014, 100(2), 75-82.
[PMID: 24639430]

Tanio, S.S.; Habowski, A.N.; Pate, K.T.; McQuade, M.M.; Wang, K.; Edwards, R.A.; Grun, F.; Lyou, Y.; Waterman, M.L. Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer. Cancer Metab., 2016, 4(1), 20.
[http://dx.doi.org/10.1186/s40170-016-0159-3] [PMID: 27729975]

Chen, X.; Chen, X.; Liu, F.; Yuan, Q.; Zhang, K.; Zhou, W.; Guan, S.; Wang, Y.; Mi, S.; Cheng, Y. Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma. Oncol. Rep., 2019, 41(4), 2529-2539.
[http://dx.doi.org/10.3892/or.2019.6992] [PMID: 30720131]

Rozhin, J.; Sameni, M.; Ziegler, G.; Sloane, B.F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res., 1994, 54(24), 6517-6525.
[PMID: 7987851]

Shi, Q.; Le, X.; Wang, B.; Abbruzzese, J.L.; Xiong, Q.; He, Y.; Xie, K. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene, 2001, 20(28), 3751-3756.
[http://dx.doi.org/10.1038/sj.onc.1204500] [PMID: 11439338]

Swietach, P.; Jones, V.R.D.; Harris, A.L. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev., 2007, 26(2), 299-310.
[http://dx.doi.org/10.1007/s10555-007-9064-0] [PMID: 17415526]

Xu, L.; Fidler, I.J. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res., 2000, 60(16), 4610-4616.
[PMID: 10969814]

Hou, L.; Zhao, Y.; Song, G.; Ma, Y.; Jin, X.; Jin, S.; Fang, Y.; Chen, Y. Interfering cellular lactate homeostasis overcomes taxol resistance of breast cancer cells through the microrna-124-mediated lactate transporter (MCT1) inhibition. Cancer Cell Int., 2019, 19(1), 193.
[http://dx.doi.org/10.1186/s12935-019-0904-0] [PMID: 31367191]

Andersen, A.P.; Flinck, M.; Oernbo, E.K.; Pedersen, N.B.; Viuff, B.M.; Pedersen, S.F. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol. Cancer, 2016, 15(1), 45.
[http://dx.doi.org/10.1186/s12943-016-0528-0] [PMID: 27266704]

Cordoba, R.S.L.; Cuevas, R.S.; Pina, B.V.; Aziz, M.A.; D’Ippolito, E.; Cosentino, G.; Baroni, S.; Iorio, M.V.; Miranda, H.A. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Sci. Rep., 2018, 8(1), 12252.
[http://dx.doi.org/10.1038/s41598-018-29708-9] [PMID: 30115973]

Dobruch, J.; Oszczudłowski, M. Bladder cancer: Current challenges and future directions. Medicina , 2021, 57(8), 749.
[http://dx.doi.org/10.3390/medicina57080749] [PMID: 34440955]

Wu, K.; Zeng, J.; Zhou, J.; Fan, J.; Chen, Y.; Wang, Z.; Zhang, T.; Wang, X.; He, D. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Urol. Oncol., 2013, 31(8), 1751-1760.
[http://dx.doi.org/10.1016/j.urolonc.2012.02.001] [PMID: 22421353]

Chiang, C.Y.; Pan, C.C.; Chang, H.Y.; Lai, M.D.; Tzai, T.S.; Tsai, Y.S.; Ling, P.; Liu, H.S.; Lee, B.F.; Cheng, H.L.; Ho, C.L.; Chen, S.H.; Chow, N.H. SH3BGRL3 protein as a potential prognostic biomarker for urothelial carcinoma: A novel binding partner of epidermal growth factor receptor. Clin. Cancer Res., 2015, 21(24), 5601-5611.
[http://dx.doi.org/10.1158/1078-0432.CCR-14-3308] [PMID: 26286913]

Logotheti, S.; Marquardt, S.; Gupta, S.K.; Richter, C.; Edelhäuser, B.A.H.; Engelmann, D.; Brenmoehl, J.; Söhnchen, C.; Murr, N.; Alpers, M.; Singh, K.P.; Wolkenhauer, O.; Heckl, D.; Spitschak, A.; Pützer, B.M. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during bladder cancer progression as target and co-activator of E2F1. Theranostics, 2020, 10(21), 9620-9643.
[http://dx.doi.org/10.7150/thno.44176] [PMID: 32863950]

Liu, H.Y.; Lu, S.R.; Guo, Z.H.; Zhang, Z.S.; Ye, X.; Du, Q.; Li, H.; Wu, Q.; Yu, B.; Zhai, Q.; Liu, J.L. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer. J. Investig. Med., 2020, 68(1), 52-59.
[http://dx.doi.org/10.1136/jim-2019-001080] [PMID: 31371390]

Zhang, H.; Jin, S.; Ji, A.; Ma, Y.; Zhang, C.; Wang, A.; Wang, R. LncRNA SLC16A1-AS1 suppresses cell proliferation in cervical squamous cell carcinoma (cscc) through the miR-194/SOCS2 axis. Cancer Manag. Res., 2021, 13, 1299-1306.
[http://dx.doi.org/10.2147/CMAR.S276629] [PMID: 33603475]

Fakhry, C.; Westra, W.H.; Wang, S.J.; van Zante, A.; Zhang, Y.; Rettig, E.; Yin, L.X.; Ryan, W.R.; Ha, P.K.; Wentz, A.; Koch, W.; Richmon, J.D.; Eisele, D.W.; D’Souza, G. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer, 2017, 123(9), 1566-1575.
[http://dx.doi.org/10.1002/cncr.30353] [PMID: 28241096]

Speight, P.M.; Epstein, J.; Kujan, O.; Lingen, M.W.; Nagao, T.; Ranganathan, K.; Vargas, P. Screening for oral cancer-A perspective from the global oral cancer forum. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 2017, 123(6), 680-687.
[http://dx.doi.org/10.1016/j.oooo.2016.08.021] [PMID: 27727113]

Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Tieulent, L.J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin., 2015, 65(2), 87-108.
[http://dx.doi.org/10.3322/caac.21262] [PMID: 25651787]

Li, T.; Wang, D.; Yang, S. Analysis of the subcellular location of lncRNA SLC16A1-AS1 and its interaction with premature miR-5088-5p in oral squamous cell carcinoma. Odontology, 2023, 111(1), 41-48.
[PMID: 35829849]

Feng, H.; Zhang, X.; Lai, W.; Wang, J. Long non-coding RNA SLC16A1-AS1: Its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma. Cell Cycle, 2020, 19(13), 1641-1653.
[http://dx.doi.org/10.1080/15384101.2020.1762048] [PMID: 32450050]

Pei, S.; Chen, Z.; Tan, H.; Fan, L.; Zhang, B.; Zhao, C. SLC16A1-AS1 enhances radiosensitivity and represses cell proliferation and invasion by regulating the miR-301b-3p/CHD5 axis in hepatocellular carcinoma. Environ. Sci. Pollut. Res. Int., 2020, 27(34), 42778-42790.
[http://dx.doi.org/10.1007/s11356-020-09998-1] [PMID: 32748357]

Song, M.; Zhong, A.; Yang, J.; He, J.; Cheng, S.; Zeng, J.; Huang, Y.; Pan, Q.; Zhao, J.; Zhou, Z.; Zhu, Q.; Tang, Y.; Chen, H.; Yang, C.; Liu, Y.; Mo, X.; Weng, D.; Xia, J.C. Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma. Aging, 2019, 11(22), 10422-10453.
[http://dx.doi.org/10.18632/aging.102468] [PMID: 31761783]

Tian, J.; Hu, D. LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival. Clin. Res. Hepatol. Gastroenterol., 2021, 45(2), 101490.
[http://dx.doi.org/10.1016/j.clinre.2020.07.001] [PMID: 33744723]

Rothzerg, E.; Ho, X.D.; Xu, J.; Wood, D.; Märtson, A.; Kõks, S. Upregulation of 15 antisense long non-coding rnas in osteosarcoma. Genes, 2021, 12(8), 1132.
[http://dx.doi.org/10.3390/genes12081132] [PMID: 34440306]

Duan, C. LncRNA SLC16A1‐AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR‐411/MITD1 axis. J. Clin. Lab. Anal., 2022, 36(4), e24344.
[http://dx.doi.org/10.1002/jcla.24344] [PMID: 35293026]

Cancela, G.I.; Caja, L. The TGF-β family in glioblastoma. Int. J. Mol. Sci., 2024, 25(2), 1067.
[http://dx.doi.org/10.3390/ijms25021067] [PMID: 38256140]

Zhang, Y.; Cruickshanks, N.; Pahuski, M.; Yuan, F.; Dutta, A.; Schiff, D.; Purow, B.; Abounader, R. Noncoding RNAs in Glioblastoma. Glioblastoma [Internet]; Brisbane (AU): Codon Publications, 2017.
[http://dx.doi.org/10.15586/codon.glioblastoma.2017.ch6]

Bai, X.; Wang, Q.; Rui, X.; Li, X.; Wang, X. Upregulation of miR-1269 contributes to the progression of esophageal squamous cell cancer cells and is associated with poor prognosis. Technol. Cancer Res. Treat., 2021, 20, 1533033820985858.
[http://dx.doi.org/10.1177/1533033820985858] [PMID: 33416035]

Yu, S.N.; Miao, Y.Y.; Zhang, B.T.; Dai, Y.M.; Liu, L.; Gao, Z.L.; Liu, G.F. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-β1 expression. Eur. Rev. Med. Pharmacol. Sci., 2021, 25(7), 2824.
[PMID: 33877675]

Liu, W.L.; Wang, H.; Shi, C.; Shi, F.; Zhao, L.; Zhao, W.; Wang, G. MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer. Cancer Cell Int., 2019, 19(1), 308.
[http://dx.doi.org/10.1186/s12935-019-1026-4] [PMID: 31768130]

Jin, Z.; Li, H.; Long, Y.; Liu, R.; Ni, X. MicroRNA-1269 is downregulated in glioblastoma and its maturation is regulated by long non-coding RNA SLC16A1 Antisense RNA 1. Bioengineered, 2022, 13(5), 12749-12759.
[http://dx.doi.org/10.1080/21655979.2022.2070581] [PMID: 35609320]

González, S.I.; Bobien, A.; Molnar, C.; Schmid, S.; Strotbek, M.; Boerries, M.; Busch, H.; Olayioye, M.A. miR-149 suppresses breast cancer metastasis by blocking paracrine interactions with macrophages. Cancer Res., 2020, 80(6), 1330-1341.
[http://dx.doi.org/10.1158/0008-5472.CAN-19-1934] [PMID: 31911555]

Long, Y.; Li, H.; Jin, Z.; Zhang, X. LncRNA slc16a1-as1 is upregulated in glioblastoma and promotes cancer cell proliferation by regulating mir-149 methylation. Cancer Manag. Res., 2021, 13, 1215-1223.
[http://dx.doi.org/10.2147/CMAR.S264613] [PMID: 33603467]

Tari, D.U. Breast cancer: A multi-disciplinary approach from imaging to therapy. Curr. Oncol., 2024, 31(1), 598-602.
[http://dx.doi.org/10.3390/curroncol31010043] [PMID: 38275836]

Jiang, B.; Xia, J.; Zhou, X. Overexpression of lncrna slc16a1-as1 suppresses the growth and metastasis of breast cancer via the miR-552-5p/WIF1 signaling pathway. Front. Oncol., 2022, 12, 712475.
[http://dx.doi.org/10.3389/fonc.2022.712475] [PMID: 35372039]

Seok, H.J.; Choi, J.Y.; Yi, J.M.; Bae, I.H. Targeting miR-5088-5p attenuates radioresistance by suppressing slug. Noncoding RNA Res., 2023, 8(2), 164-173.
[http://dx.doi.org/10.1016/j.ncrna.2022.12.005] [PMID: 36632615]

Seok, H.J.; Choi, Y.E.; Choi, J.Y.; Yi, J.M.; Kim, E.J.; Choi, M.Y.; Lee, S.J.; Bae, I.H. Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2. Mol. Ther. Nucleic Acids, 2021, 25, 127-142.
[http://dx.doi.org/10.1016/j.omtn.2021.05.004] [PMID: 34457998]

Vagia, E.; Mahalingam, D.; Cristofanilli, M. The landscape of targeted therapies in tNBC. Cancers , 2020, 12(4), 916.
[http://dx.doi.org/10.3390/cancers12040916] [PMID: 32276534]

Jiang, B.; Liu, Q.; Gai, J.; Guan, J.; Li, Q. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle. Immunopharmacol. Immunotoxicol., 2022, 44(4), 534-540.
[http://dx.doi.org/10.1080/08923973.2022.2056482] [PMID: 35316129]

Bohosova, J.; Kasik, M.; Kubickova, A.; Trachtova, K.; Stanik, M.; Poprach, A.; Slaby, O. LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro. J. Clin. Lab. Anal., 2022, 36(6), e24442.
[http://dx.doi.org/10.1002/jcla.24442] [PMID: 35441392]

Liu, S.; Yu, Y.; Wang, Y.; Zhu, B.; Han, B. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks. Eur. J. Med. Res., 2022, 27(1), 122.
[http://dx.doi.org/10.1186/s40001-022-00745-5] [PMID: 35842702]

Li, Y.; Zhu, H.C.; Du, Y.; Zhao, H.; Wang, L. Silencing lncrna slc16a1-as1 induced ferroptosis in renal cell carcinoma through mir-143-3p/slc7a11 signaling. Technol. Cancer Res. Treat., 2022, 21, 15330338221077803.
[http://dx.doi.org/10.1177/15330338221077803] [PMID: 35167383]